|
Getting your Trinity Audio player ready...
|
South African Olympic champion Caster Semenya has officially ended her long-standing legal battle against World Athletics’ sex eligibility regulations, closing a chapter that has spanned more than seven years and reshaped the conversation around gender and fairness in sports.
End of a Prolonged Legal Struggle
According to her legal team, Semenya will not pursue any further appeals following her partial victory at the European Court of Human Rights (ECHR) earlier this year. Patrick Bracher, one of her attorneys, confirmed that their client’s challenge has reached its conclusion after achieving a “highly successful outcome” at Europe’s top human rights court. The ECHR had ruled in July that Semenya did not receive a fair hearing in a previous case before Switzerland’s Federal Tribunal.
While that decision gave Semenya the option to reopen the case before Swiss courts, her legal representatives have now stated that no additional legal steps will be taken.
Background of the Case
Semenya, a two-time Olympic gold medalist in the women’s 800 meters, has been barred from competing in her signature event at major international competitions since 2019. The restriction stems from World Athletics regulations that require female athletes with certain differences in sex development (DSD) to take medication that lowers their naturally high testosterone levels.
Since the introduction of these rules in 2018, Semenya has challenged them in multiple courts, including:
- The Court of Arbitration for Sport (CAS),
- The Swiss Federal Tribunal,
- And finally, the European Court of Human Rights.
Although she lost her appeals at CAS and the Swiss Tribunal, the ECHR’s ruling offered a glimmer of hope by highlighting procedural flaws in the earlier decisions.
Impact on Her Career
Once the dominant figure in middle-distance running, Semenya went unbeaten in more than 30 consecutive races before the rules forced her out of international competition. Now aged 34, she has transitioned into coaching and athlete development, with the regulations effectively marking the end of her competitive career.
Understanding the DSD Debate
Semenya’s case has been central to global debates about DSD athletes, individuals born with variations in sex characteristics that do not fit typical definitions of male or female. She possesses XY chromosomes and elevated natural testosterone levels but was identified female at birth and has always competed as a woman.
World Athletics argues that athletes with testosterone levels in the typical male range have a competitive edge due to the hormone’s influence on strength and endurance. However, this claim remains scientifically contested, with experts divided over the actual extent of the advantage.
Importantly, Semenya’s case is distinct from discussions around transgender athletes. She is not transgender but intersex, a difference that is often misunderstood in public discourse.
Evolving Regulations
Since Semenya’s initial challenge, World Athletics has tightened its eligibility rules. The latest update, which took effect on September 1, 2025, moves beyond testosterone monitoring and now requires a genetic sex verification test. Under the new policy, female athletes who possess a Y chromosome are prohibited from competing in women’s events.
Semenya’s lawyer noted that these new regulations differ significantly from the ones originally contested, but the ECHR’s decision could lay groundwork for future legal challenges by other athletes affected under the updated framework.
Wider Sports Implications
Semenya’s fight has influenced other sports to adopt similar measures. Swimming, for example, has implemented restrictions on DSD athletes, while boxing has introduced genetic testing following controversies at the 2024 Paris Olympics involving Algerian boxer Imane Khelif and Taiwan’s Lin Yu-ting. Khelif, who won gold in Paris, is now appealing the new rules at the Court of Arbitration for Sport.
A Legacy Beyond the Track
While her legal battle has ended, Semenya’s influence on global sports policy and human rights remains profound. Her case continues to raise essential questions about inclusivity, scientific fairness, and the rights of athletes born with natural biological variations. For many, she stands as a symbol of resilience and advocacy for equality in athletics.